Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01078077
Other study ID # 10-005
Secondary ID
Status Recruiting
Phase N/A
First received March 1, 2010
Last updated March 1, 2012
Start date March 2010
Est. completion date July 2012

Study information

Verified date March 2012
Source East Suburban Ob Gyn
Contact michael j pelekanos, MD
Phone 4128567500
Email mipels@aol.com
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if a topical vasodilating cream will improve female sexual experience.


Description:

To determine in a placebo controlled double blinded study whether a topically applied vasodilating cream will improve the female sexual response as measured by a standard female sexual dysfunction questionnaire


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date July 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- Healthy females ages 25 to sixty sexually active

Exclusion Criteria:

- Neurologic disease, on SSRI's,advanced diabetes, non sexually active, mentally incompetent

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States East Suburban Obgyn Monroeville Pennsylvania
United States West Penn Allegheny Health Center Monroeville Pennsylvania
United States West Penn Hospital Forbes Campus Monroeville Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Michael Pelekanos MD West Penn Allegheny Health System

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT05806424 - Investigation of Awareness Levels of Women Living in Turkey About Kegel Exercises and Pelvic Floor Muscles
Completed NCT01364623 - PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women Phase 1
Completed NCT06060691 - the Ameliorating Effects of Antioxidant Gel on Female Arousal Disorder and Sexual Dysfunction Phase 1
Recruiting NCT04419961 - Sexual Dysfunction and an Educational Program to Improve the Quality of Sexual Function in Vietnamese Pregnant Women in First Trimester N/A
Completed NCT04122703 - Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction N/A
Recruiting NCT03498443 - Effect of Pelvic Organ Prolapse Surgeries on Female Sexual Function in Egyptian Women
Completed NCT03232801 - A Mindfulness-based Intervention for Older Women With Low Sexual Desire N/A
Completed NCT04124640 - Observational Study in Real Life to Describe the Libicare® Effectiveness in Female Sexual Dysfunction.
Completed NCT00995072 - Comparative Effects of Nebivolol and Metoprolol on Female Sexual Function N/A
Active, not recruiting NCT05168371 - Cognitive-Behavioural & Mindfulness-Based Online Programs for Female Sexual Dysfunction N/A
Completed NCT04384172 - Effect of Peripheral Neuromodulation on Vaginal Blood Flow N/A
Recruiting NCT06237166 - Evaluation of an Online Intervention for Female Sexual Dysfunction N/A
Completed NCT03463707 - BP101 for Adults With Female Sexual Dysfunction Phase 3
Completed NCT01724658 - Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Phase 2
Completed NCT02229721 - Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women Phase 2
Completed NCT00479570 - Study To Investigate Effect Of A New Drug (PF-00446687) In Post-Menopausal Women Who Suffer From Sexual Dysfunction. Phase 2
Not yet recruiting NCT06116045 - Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder Phase 2
Withdrawn NCT02862184 - Female Sexual Dysfunction, Risks and Outcomes (FSFI) N/A
Completed NCT01195701 - Clitoral Location in Relation to Sexual Function Using Pelvic Imaging N/A
Completed NCT04484753 - Validation of iPelvis App for Female Pelvic Floor Dysfunction N/A